Sanara MedTech vs Kestra Medical Technologies vs STAAR Surgical
Score, categories, valuation, dividend, crash risk and price performance of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical side by side. Figures from the overnight run, closing prices from 19 Nov 2026.
Key figures compared
| SMTISanara MedTech | KMTSKestra Medical Technologies | STAASTAAR Surgical | |
|---|---|---|---|
| MEQIRI Score | |||
| Score | 61 | 39 | 44 |
| Fundamentals | 39 | 17 | 40 |
| Growth | 70 | 50 | 45 |
| Profitability | 87 | 17 | 33 |
| Valuation | 48 | no data | 29 |
| Technical analysis | 76 | 63 | 63 |
| Momentum | 87 | 64 | 47 |
| Stability | 29 | 52 | 71 |
| Capital allocation | 45 | 25 | 30 |
| Price and valuation | |||
| Closing price | $32.67 | $26.63 | $25.03 |
| Market cap | $300M | $1.59B | $1.26B |
| P/E | Loss | Loss | 2,429.8 |
| Forward P/E | no data | Loss expected | 45.0 |
| Fair value | $36.27 | no data | $18.05 |
| Fair value versus price | +11.0% | no data | −27.9% |
| Growth and dividend | |||
| Revenue growth per year | +45.9% | no data | +11.7% |
| Dividend yield | 0.0% | 0.0% | 0.0% |
| Risk and performance | |||
| Crash risk | high36 in 100 | no data | high36 in 100 |
| Price 1 year | +71.4% | +3.1% | −5.4% |
| Price 5 years | +4.3% | no data | −77.3% |
| Industry | Medical (Instruments & Supplies) | Medical (Instruments & Supplies) | Medical (Instruments & Supplies) |
Score and figures from the overnight run, closing prices from 19 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.
Price performance
- Sanara MedTech
- Kestra Medical Technologies
- STAAR Surgical
All lines start at 100 on 6 March 2025, the first trading day of the youngest stock. Closing prices without dividends, each stock in its trading currency.
Questions and Answers
How do Sanara MedTech, Kestra Medical Technologies and STAAR Surgical compare on the MEQIRI Score?
The MEQIRI Score (0 to 100) is 61 for Sanara MedTech, 39 for Kestra Medical Technologies and 44 for STAAR Surgical. The category Profitability differs most, with 87 for Sanara MedTech, 17 for Kestra Medical Technologies and 33 for STAAR Surgical. The score combines eight categories and is recalculated every night.
What is the P/E ratio of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?
Sanara MedTech: P/E Loss, forward P/E no data. Kestra Medical Technologies: P/E Loss, forward P/E Loss expected. STAAR Surgical: P/E 2,429.8, forward P/E 45.0. As of the close on 19 Nov 2026.
What is the dividend yield of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?
Sanara MedTech: 0.0%. Kestra Medical Technologies: 0.0%. STAAR Surgical: 0.0%. Based on payments over the last twelve months.
What is the crash risk of Sanara MedTech, Kestra Medical Technologies and STAAR Surgical?
Sanara MedTech: Crash risk high (36 in 100). Kestra Medical Technologies: no data. STAAR Surgical: Crash risk high (36 in 100). Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.
Why does the price chart start at 100?
All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.
Does the comparison tell me which stock to buy?
No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.
